Ho Jenni, Sukati Suriyan, Taylor Tamara, Carter Sherry, Fuller Brittany, Marmo Amy, Sorge Caryn, D'Orazio John, Butterfield D Allan, Bondada Subbarao, Weiss Heidi, St Clair Daret K, Chaiswing Luksana
Department of Toxicology and Cancer Biology, University of Kentucky, USA; Markey Cancer Center, University of Kentucky, USA.
Department of Medical Technology, Walailak University, Thailand.
Free Radic Biol Med. 2025 Feb 1;227:312-321. doi: 10.1016/j.freeradbiomed.2024.12.006. Epub 2024 Dec 4.
Off-target neuronal injury is a serious side-effect observed in cancer survivors. It has previously been shown that pediatric acute lymphoblastic leukemia (ALL) survivors have a decline in neurocognition compared to healthy age-matched counterparts. Elevated oxidative stress has been documented to be a mediator in off-target tissue damage in cancer survivors. Early detection of oxidative stress markers may provide an opportunity to prevent off-target tissue damage. Extracellular vesicles (EVs) have surfaced as a potential diagnostic tool due to molecular cargo they contain. We investigated the potential for EVs to be a sensitive indicator of oxidative stress and off-target tissue damage by isolating EVs from pediatric ALL patients throughout their first 2 months of treatment. EVs were measured throughout the collection points for: 1) number of EV particles generated using nanoparticle tracking analysis (NTA); 2) markers of neurons (NeuN), astrocyte activation (GFAP), neuronal stability (BDNF), 3) markers of pre-B cell ALL (CD19 and CD22); and) 4-hydroxy-2-nonenal (HNE) adducted proteins. HNE protein adductions were measured in the patient sera and CSF. Pro-inflammatory cytokine levels were also measured in patient sera because of their contribution to oxidative stress and neuronal injury. Our results: 1) demonstrate EVs are a sensitive indicator of oxidative damage; 2) suggest EVs as a marker of a decline in neuronal stability; and 3) show the presence of leukemia has a greater contribution to pro-inflammatory cytokine production in the patient's serum than the cancer treatment. Specifically, we observed a significant decrease in cytokine levels (e.g., TNF-α, IL-1β, IL-6, and IL-8) following the initiation of treatment, highlighting the influence of leukemia burden on systemic inflammation. The results support the utilization of EVs as a sensitive marker of oxidative stress and off-target tissue damage.
脱靶性神经元损伤是癌症幸存者中观察到的一种严重副作用。此前已有研究表明,与年龄匹配的健康儿童相比,小儿急性淋巴细胞白血病(ALL)幸存者的神经认知能力有所下降。有文献记载,氧化应激升高是癌症幸存者脱靶组织损伤的一个介导因素。氧化应激标志物的早期检测可能为预防脱靶组织损伤提供机会。细胞外囊泡(EVs)因其所含的分子货物而成为一种潜在的诊断工具。我们通过在小儿ALL患者治疗的前2个月内分离EVs,研究了EVs作为氧化应激和脱靶组织损伤敏感指标的潜力。在整个收集点测量EVs:1)使用纳米颗粒跟踪分析(NTA)生成的EV颗粒数量;2)神经元标志物(NeuN)、星形胶质细胞活化标志物(GFAP)、神经元稳定性标志物(BDNF);3)前B细胞ALL标志物(CD19和CD22);以及4-羟基-2-壬烯醛(HNE)加合物蛋白。在患者血清和脑脊液中测量HNE蛋白加合物。由于促炎细胞因子对氧化应激和神经元损伤有影响,因此也在患者血清中测量其水平。我们的结果:1)证明EVs是氧化损伤的敏感指标;2)表明EVs可作为神经元稳定性下降的标志物;3)表明白血病的存在对患者血清中促炎细胞因子产生的贡献比癌症治疗更大。具体而言,我们观察到治疗开始后细胞因子水平(如TNF-α、IL-1β、IL-6和IL-8)显著下降,突出了白血病负担对全身炎症的影响。这些结果支持将EVs用作氧化应激和脱靶组织损伤的敏感标志物。